Access to immunotherapy update

As you may be aware from previous issues of our magazine, first line immunotherapy (nivolumab and ipilimumab) for the treatment of mesothelioma is currently under consideration by the National Institute for Health and Care Excellence (NICE) following the results of the CHECKMATE 743 study.

The decision about whether this treatment would be recommended and therefore available on the NHS was expected at the end of April. Unfortunately, NICE has put this on hold to allow for commercial negotiations to take place.

A single immunotherapy has been available on the NHS for second line treatment of mesothelioma since summer 2020 as part of a response to Covid19. This is kept under regular review and we anticipate that it will be reviewed again in June. It is unclear whether this access will continue and whether it will be affected by the outcome of the NICE appraisal for first line treatment. We understand that people being treated with nivolumab will be able to continue the treatment as long as it is effective, even if it withdrawn.

We will update through our social media channels on Facebook and Twitter when we receive any more information.

Introducing the new Health Companion portal

Working in collaboration with DaSH-Global, a pharmaceutical manufacturing company, we have developed a new digital patient portal known as the ‘Health Companion’. The new system will allow patients to submit data regarding their quality of life and experiences in the...

Join our Asbestos Commercial Club

If you are a business involved in the management of asbestos or the diseases it causes, why not join our Asbestos Commercial Club (MUKACC) to support the vital work that we do? Joining MUKACC can be a great morale booster for your staff, encouraging them to get...

CEO Liz Darlison to speak at the European Asbestos Conference

Mesothelioma UK’s CEO, Liz Darlison, has been confirmed as a speaker at the European Asbestos Forum Conference (EAF). The event will take place from 10-11 November in Amsterdam, in the Netherlands, where she will deliver a talk entitled, Establishing a National...

Mesothelioma National Statistics

The Health and Safety Executive has been publishing statistics on annual mesothelioma deaths in Great Britain on a consistent basis for 50 years. Detailed statistical tables and commentary are available as part of HSE’s National Statistics web pages here. The data...